TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
TALPHERA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.08+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $81.57M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
54.4%
28M of 52M shares
Institutional holders
49
13 new, 8 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $304.35K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| CorMedix Inc. | 9,090,909 | 19.95% | 13D (active) | Sep 7, 2025 |
| Salamon Steven A J | 7,642,515 | 9.90% | 13G (passive) | Mar 31, 2025 |
| AIGH Capital Management LLC | 4,661,502 | 9.80% | 13G (passive) amendment | Dec 31, 2025 |
| Orin Hirschman | 4,454,545 | 9.70% | 13G (passive) | Sep 30, 2025 |
| Rock Springs Capital Management LP | 3,589,186 | 7.88% | 13G (passive) | Sep 10, 2025 |
| Lytton Laurence W | 2,730,718 | 5.90% | 13G (passive) amendment | Dec 31, 2025 |
| Nantahala Capital Management, LLC | 1,992,519 | 11.70% | 13D (active) amendment | Mar 31, 2025 |
| Daniel Mack | 1,992,519 | 11.70% | 13D (active) amendment | Mar 31, 2025 |
| Rosalind Master Fund L.P. | 13,957,438 | 9.90% | 13G (passive) amendment | Sep 30, 2025 |
| Aharon Gil | 12,925,597 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| Rosalind Advisors, Inc. | 12,913,182 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TLPH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6,985,038 | 13.46% | $7.19M | +3,492,519 | 0.12% |
| Rosalind Advisors, Inc. | 5,169,501 | 9.96% | $5.32M | +1,815,585 | 1.98% |
| AIGH Capital Management LLC | 4,601,502 | 8.87% | $4.74M | −60,000 | 0.30% |
| Rock Springs Capital Management LP | 3,589,186 | 6.91% | $3.70M | – | 0.18% |
| Cantor Fitzgerald, L. P. | 1,774,962 | 3.42% | $1.83M | +887,481 | 0.01% |
| Bleichroeder LP | 1,307,787 | 2.52% | $1.35M | – | 0.24% |
| Dauntless Investment Group, LLC | 746,051 | 1.44% | $768.43K | +310,817 | 0.60% |
| Vanguard Capital Management LLC | 701,877 | 1.35% | $722.93K | +260,266 | 0.00% |
| Caption Management, LLC | 514,969 | 0.99% | $530.42K | −46,851 | 0.00% |
| Almitas Capital LLC | 467,152 | 0.90% | $481.17K | – | 0.12% |
| Geode Capital Management, LLC | 429,062 | 0.83% | $442.00K | +9,082 | 0.00% |
| Shay Capital LLC | 405,764 | 0.78% | $417.94K | +155,681 | 0.03% |
| Vanguard Fiduciary Trust Co | 222,372 | 0.43% | $229.04K | +29,967 | 0.00% |
| Gsa Capital Partners Llp | 209,355 | 0.40% | $216 | +115,567 | 0.01% |
| Diadema Partners LP | 153,563 | 0.30% | $158.17K | – | 0.02% |
| UBS Group AG | 129,916 | 0.25% | $133.81K | +116,092 | 0.00% |
| Renaissance Technologies LLC | 113,300 | 0.22% | $116.70K | −124,455 | 0.00% |
| Mariner, LLC | 100,000 | 0.19% | $103.00K | – | 0.00% |
| BlackRock, Inc. | 91,548 | 0.18% | $94.29K | – | 0.00% |
| Northern Trust Corp | 88,296 | 0.17% | $90.95K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 49 | 28M | 54.4% | 13 / 14 | 6 / 8 | 7M | 1M |
| Q1 2026 | 45 | 22M | 42.1% | 13 / 12 | 7 / 4 | 3M | 1M |
| Q4 2025 | 38 | 21M | 40.2% | 10 / 11 | 6 / 6 | 4M | 1M |
| Q3 2025 | 34 | 18M | 34.3% | 7 / 11 | 4 / 5 | 13M | 0M |
| Q2 2025 | 32 | 5M | 10.2% | 4 / 4 | 9 / 4 | 0M | 0M |
| Q1 2025 | 32 | 6M | 10.6% | 4 / 9 | 7 / 6 | 2M | 0M |
| Q4 2024 | 35 | 4M | 7.9% | 10 / 4 | 7 / 4 | 0M | 0M |
| Q3 2024 | 29 | 4M | 8.0% | 4 / 4 | 9 / 4 | 0M | 2M |
| Q2 2024 | 30 | 6M | 12.2% | 3 / 5 | 10 / 4 | 2M | 0M |
| Q1 2024 | 31 | 4M | 8.6% | 4 / 11 | 8 / 6 | 1M | 2M |
| Q4 2023 | 33 | 5M | 10.1% | 6 / 10 | 6 / 4 | 2M | 0M |
| Q3 2023 | 31 | 3M | 6.3% | 9 / 8 | 4 / 5 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TLPH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 440,104 | 0.85% | $453.31K | 0.00% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 261,773 | 0.50% | $269.63K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 208,775 | 0.40% | $170.36K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 63,382 | 0.12% | $51.72K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 52,389 | 0.10% | $42.75K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 16,366 | 0.03% | $13.35K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER, Director | 790,767 | 1.52% | Apr 3, 2026 |
| Shakil Aslam | Chief Medical Officer | 76,542 | 0.15% | May 21, 2026 |
| Badri N. Dasu | Chief Engineering Officer | 71,440 | 0.14% | Apr 3, 2026 |
| Raffi Asadorian | Chief Financial Officer | 85,879 | 0.17% | Apr 3, 2026 |
| Jill Marie Broadfoot | Director | 13,647 | 0.03% | Jun 24, 2026 |
| Joseph Todisco | Director | 11,497 | 0.02% | Jun 24, 2026 |
| Marina Bozilenko | Director | 14,147 | 0.03% | Jun 24, 2026 |
| Abhinav Jain | Director | 12,412 | 0.02% | Jun 24, 2026 |
| Adrian Adams | Director | 22,709 | 0.04% | Jun 24, 2026 |
| Mark A. Wan | Director | 140,112 | 0.27% | Jun 24, 2026 |
| Stephen J. Hoffman | Director | 2,885,892 | 5.56% | Jun 24, 2026 |
| Daniel Mack | 10% owner | 1,992,519 | 3.84% | Mar 17, 2026 |
| Wilmot B. Harkey | 10% owner | – | – | Mar 17, 2026 |
| Nantahala Capital Management, LLC | 10% owner | – | – | Mar 17, 2026 |
| Inc. CorMedix | 10% owner | 9,090,909 | 17.51% | Sep 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Abhinav Jain Director | Jun 22, 2026 | Award | +5,100 | – | – | 12,412 |
| Adrian Adams Director | Jun 22, 2026 | Award | +5,100 | – | – | 22,709 |
| Mark A. Wan Director | Jun 22, 2026 | Award | +5,100 | – | – | 13,959 |
| Stephen J. Hoffman Director | Jun 22, 2026 | Award | +5,100 | – | – | 13,959 |
| Marina Bozilenko Director | Jun 22, 2026 | Award | +5,100 | – | – | 14,147 |
| Jill Marie Broadfoot Director | Jun 22, 2026 | Award | +5,100 | – | – | 13,647 |
| Joseph Todisco Director | Jun 22, 2026 | Award | +5,100 | – | – | 11,497 |
| Shakil Aslam Chief Medical Officer | May 20, 2026 | Tax withholding | −4,518 | $0.82 | $3.70K | 76,542 |
| Raffi Asadorian Chief Financial Officer | Apr 2, 2026 | Tax withholding | −2,444 | $0.72 | $1.76K | 85,879 |
| Shakil Aslam Chief Medical Officer | Apr 2, 2026 | Tax withholding | −2,118 | $0.72 | $1.52K | 81,060 |
| Badri N. Dasu Chief Engineering Officer | Apr 2, 2026 | Tax withholding | −2,444 | $0.72 | $1.76K | 71,440 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Apr 2, 2026 | Tax withholding | −9,938 | $0.72 | $7.16K | 790,767 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Mar 13, 2026 | Buy | +213,310 | $0.59 | $125.85K | 800,705 |
| Badri N. Dasu Chief Engineering Officer | Feb 14, 2026 | Tax withholding | −2,346 | $0.79 | $1.85K | 73,884 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 14, 2026 | Tax withholding | −9,559 | $0.79 | $7.55K | 577,395 |
| Raffi Asadorian Chief Financial Officer | Feb 14, 2026 | Tax withholding | −2,933 | $0.79 | $2.32K | 88,323 |
| Shakil Aslam Chief Medical Officer | Feb 12, 2026 | Buy | +35,000 | $0.81 | $28.35K | 83,178 |
| Badri N. Dasu Chief Engineering Officer | Feb 12, 2026 | Buy | +35,000 | $0.81 | $28.35K | 76,230 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 12, 2026 | Buy | +105,364 | $0.81 | $85.34K | 586,954 |
| Raffi Asadorian Chief Financial Officer | Feb 12, 2026 | Buy | +45,000 | $0.81 | $36.45K | 91,256 |
| Badri N. Dasu Chief Engineering Officer | Feb 10, 2026 | Tax withholding | −781 | $0.84 | $656 | 41,230 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 10, 2026 | Tax withholding | −3,179 | $0.84 | $2.67K | 481,590 |
| Raffi Asadorian Chief Financial Officer | Feb 10, 2026 | Tax withholding | −958 | $0.84 | $805 | 46,256 |
| Stephen J. Hoffman Director | Oct 23, 2025 | Award | +4,267 | – | – | 8,859 |
| Marina Bozilenko Director | Oct 23, 2025 | Award | +4,267 | – | – | 9,047 |
| Abhinav Jain Director | Oct 23, 2025 | Award | +4,267 | – | – | 7,312 |
| Jill Marie Broadfoot Director | Oct 23, 2025 | Award | +4,267 | – | – | 8,547 |
| Adrian Adams Director | Oct 23, 2025 | Award | +4,267 | – | – | 17,609 |
| Mark A. Wan Director | Oct 23, 2025 | Award | +4,267 | – | – | 8,859 |
| Joseph Todisco Director | Oct 15, 2025 | Award | +6,397 | – | – | 6,397 |
| Shakil Aslam Chief Medical Officer | May 20, 2025 | Tax withholding | −4,517 | $0.52 | $2.35K | 48,178 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Apr 2, 2025 | Award | +61,000 | – | – | 474,769 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Apr 2, 2025 | Buy | +213,310 | $0.59 | $125.85K | 403,769 |
| Raffi Asadorian Chief Financial Officer | Apr 2, 2025 | Award | +15,000 | – | – | 47,214 |
| Badri N. Dasu Chief Engineering Officer | Apr 2, 2025 | Award | +15,000 | – | – | 42,011 |
| Shakil Aslam Chief Medical Officer | Apr 2, 2025 | Award | +15,000 | – | – | 52,695 |
| Badri N. Dasu Chief Engineering Officer | Feb 14, 2025 | Tax withholding | −2,644 | $0.67 | $1.77K | 27,011 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 14, 2025 | Tax withholding | −10,575 | $0.67 | $7.09K | 190,459 |
| Raffi Asadorian Chief Financial Officer | Feb 14, 2025 | Tax withholding | −3,245 | $0.67 | $2.17K | 32,214 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 11, 2025 | Tax withholding | −3,517 | $0.62 | $2.18K | 201,034 |
| Badri N. Dasu Chief Engineering Officer | Feb 11, 2025 | Tax withholding | −880 | $0.62 | $546 | 29,655 |
| Raffi Asadorian Chief Financial Officer | Feb 11, 2025 | Tax withholding | −1,060 | $0.62 | $657 | 35,459 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Feb 10, 2025 | Tax withholding | −3,515 | $0.63 | $2.21K | 204,551 |
| Badri N. Dasu Chief Engineering Officer | Feb 10, 2025 | Tax withholding | −879 | $0.63 | $554 | 30,535 |
| Raffi Asadorian Chief Financial Officer | Feb 10, 2025 | Tax withholding | −1,059 | $0.63 | $667 | 36,519 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Dec 5, 2024 | Buy | +5,000 | $0.64 | $3.20K | 208,066 |
| Raffi Asadorian Chief Financial Officer | Dec 2, 2024 | Sale | −155 | $0.77 | $119 | 37,578 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Nov 27, 2024 | Buy | +5,000 | $0.73 | $3.65K | 203,066 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Aug 30, 2024 | Buy | +7,260 | $1.05 | $7.62K | 198,066 |
| Adrian Adams Director | Jun 24, 2024 | Award | +2,174 | – | – | 13,342 |
| Stephen J. Hoffman Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,592 |
| Jill Marie Broadfoot Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,280 |
| Abhinav Jain Director | Jun 24, 2024 | Award | +2,174 | – | – | 3,045 |
| Marina Bozilenko Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,780 |
| Mark A. Wan Director | Jun 24, 2024 | Award | +2,174 | – | – | 4,592 |
| Shakil Aslam Chief Medical Officer | Jun 14, 2024 | Buy | +5,000 | $1.07 | $5.35K | 37,695 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Jun 14, 2024 | Buy | +1,304 | $1.08 | $1.41K | 180,806 |
| Shakil Aslam Chief Medical Officer | Jun 13, 2024 | Buy | +695 | $0.98 | $681 | 32,695 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Jun 13, 2024 | Buy | +4,570 | $0.97 | $4.43K | 179,502 |
| Vincent J. Angotti CHIEF EXECUTIVE OFFICER, Director | Jun 12, 2024 | Buy | +4,126 | $0.97 | $4.00K | 174,932 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Raffi Asadorian Officer | Dec 2, 2024 | 155 | $107 | Dec 2, 2024 | Open Market Purchase |
| Pamela Palmer, Trustee of the Pamela P Palmer Revocable Trust DTD 10/17/2014 Officer | Aug 25, 2023 | 7,450 | $8.20K | Aug 25, 2023 | RSUs/Options Excercise |
| Pamela P. Palmer Officer, Director | Aug 24, 2023 | 9,514 | $11.18K | Aug 24, 2023 | Restricted Stock Lapse - See Remarks |